World Bulletin / News Desk
Open access worldwide to the new database, based on genome studies, is expected to help researchers accelerate development of new drugs and better match patients with therapies, NCI said in a statement on Monday.
"Most anti-cancer drugs that are used today are used based on their empirical activity," Dr. Yves Pommier, chief of the NCI's Laboratory of Molecular Pharmacology, said in an interview. "For most of them, we know there is a target, but they have not been connected with any genomics."
Most cancer treatments involve a lot of guess work because doctors have no way to determine how a particular patient is likely to respond to many commonly used drugs or chemotherapy, or which cancers will develop resistance.
To create the database, the NCI team sequenced 60 human cancer cell lines, generating an extensive list of cancer-specific variations for different parts of the body.
"Only about half of women with ovarian cancer respond to it," he said, noting that pharmaceutical companies would have little incentive to determine if an existing cancer drug should only be used in a subset of patients.
Many recently approved cancer drugs are targeted treatments, designed to block specific pathways that cancer cells use to grow and reproduce. Before the drugs are administered, patients are tested for the specific genetic mutations that would make the drug more likely to be beneficial to them.
Melanoma drug Zelboraf, sold by Roche Holding AG, is designed to work by targeting a specific genetic mutation found in about half of all melanomas. Pfizer Inc's cancer drug Xalkori, which targets a mutation in the ALK gene, works in about 4 percent of lung cancer patients.
Arab world’s biggest e-commerce retailer hopes to expand delivery capabilities, customer selection
More than 6 jobs lost for every robot installed at factories
With few details made public, speculation about Neuralink centers on the name and how it might correspond to Musk's previous statements about incorporating artificial intelligence, or AI, into human brains.
Announcement comes days before company unveils newest smartphone
Tasks focused on readying space station to accept commercial manned spacecraft
Its vice-chairman Lee Jae-Yong, heir to the parent Samsung group, has since been arrested and indicted for bribery, along with four other senior executives, in connection with the graft scandal that saw ex-president Park Geun-Hye impeached.
Google’s advertising crisis went global after some of the biggest marketers including AT&T Inc. and Johnson & Johnson halted spending on YouTube and the internet company’s display network, citing concern their ads would run alongside offensive videos.
Turkey's Roketsan, Aselsan, Turkish Aerospace Industries and Shipbuilders’ Association attend exhibition in Kedah state
The satellite will be place in orbit more that 35,000 kilometers above the earth and provide telecommunications service to Brazil, SpaceX said.
Russia's FSB hired 'criminal hackers' to attack Yahoo seeking access to journalists, diplomats, executives
New study finds that sonic waves can be exploited to compromise smartphones, fitness trackers and other gadgets
US chipmaker taking over Israeli firm for approximately $15.3 billion
The EU Chamber of Commerce said in a report state subsidies of hundreds of billions of dollars and foreign technology transfers in 10 sectors were "highly problematic" and urged China to stop interfering in the market.
Top executive Kalanick, known for being brash and aggressive in propelling Uber's rise, could now become a liability as the company deals with more complex corporate issues, say some analysts.
"This is a milestone on Norway's road to an electric car fleet," Climate and Environment Minister Vidar Helgesen said